VVRAXVirax Biolabs Group Limited

Virax Biolabs Group Limited trades on Nasdaq under the ticker VRAX. The company belongs to the Health care sector. The trading history on this page starts on 21 July 2022.

Over the past 52 weeks VRAX has traded between 1.81 $ and 21.75 $. As of 09 October 2026 the price stood 0.30 % of the way from the 52-week low to the high.

Over one year VRAX shares fell 89.03 %; over six months they fell 28.08 %. Volatility over 90 days is 172.37 %. Dividends are not included: this is price change only, as of 09 October 2026.

VRAX has a return on equity of −111.08 %, below the sector median of −41.68 %. Return on assets is −94.40 %, below the sector median of −32.11 %.